T1DMicro: A Clinical Risk Calculator for Type 1 Diabetes Related Microvascular Complications

被引:1
|
作者
Tran, Paul Minh Huy [1 ]
Kim, Eileen [1 ]
Tran, Lynn Kim Hoang [1 ]
Khaled, Bin Satter [1 ]
Hopkins, Diane [1 ]
Gardiner, Melissa [1 ]
Bryant, Jennifer [1 ]
Bernard, Risa [1 ]
Morgan, John [2 ]
Bode, Bruce [3 ]
Reed, John Chip [4 ]
She, Jin-Xiong [1 ,5 ]
Purohit, Sharad [1 ,5 ,6 ]
机构
[1] Augusta Univ, Ctr Biotechnol & Genom Med, 1120 15th Str, Augusta, GA 30912 USA
[2] Augusta Univ, Med Coll Georgia, Dept Neurol, 1120 15th Str, Augusta, GA 30912 USA
[3] Atlanta Diabet Associates, Atlanta, GA 30318 USA
[4] Southeastern Endocrine & Diabet, Atlanta, GA 30076 USA
[5] Augusta Univ, Dept Obstet & Gynecol, 1120 15th Str, Augusta, GA 30912 USA
[6] Augusta Univ, Dept Undergrad Hlth Profess, 1120 15th Str, Augusta, GA 30912 USA
关键词
type; 1; diabetes; complications; peripheral and autonomic neuropathy; retinopathy; nephropathy; risk prediction; clinical calculator; POSITION STATEMENT; NEUROPATHY; TRIAL/EPIDEMIOLOGY; INTERVENTIONS; EPIDEMIOLOGY; PREVENTION; MANAGEMENT; MORTALITY; MODELS; TRENDS;
D O I
10.3390/ijerph182111094
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Development of complications in type 1 diabetes patients can be reduced by modifying risk factors. We used a cross-sectional cohort of 1646 patients diagnosed with type 1 diabetes (T1D) to develop a clinical risk score for diabetic peripheral neuropathy (DPN), autonomic neuropathy (AN), retinopathy (DR), and nephropathy (DN). Of these patients, 199 (12.1%) had DPN, 63 (3.8%) had AN, 244 (14.9%) had DR, and 88 (5.4%) had DN. We selected five variables to include in each of the four microvascular complications risk models: age, age of T1D diagnosis, duration of T1D, and average systolic blood pressure and HbA1C over the last three clinic visits. These variables were selected for their strong evidence of association with diabetic complications in the literature and because they are modifiable risk factors. We found the optimism-corrected R2 and Harrell's C statistic were 0.39 and 0.87 for DPN, 0.24 and 0.86 for AN, 0.49 and 0.91 for DR, and 0.22 and 0.83 for DN, respectively. This tool was built to help inform patients of their current risk of microvascular complications and to motivate patients to control their HbA1c and systolic blood pressure in order to reduce their risk of these complications.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Are spirometry indices associated with microvascular complications in type 1 diabetes subjects?
    Baptist, Alma
    Dhadge, Nagesh
    Shah, Rohan
    Dhadge, Smita
    Shah, Sanjay
    Jog, Kalpana
    Yajnik, Chittaranjan
    Salvi, Sundeep
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [42] Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
    Genuth, S
    Lipps, J
    Lorenzi, G
    Nathan, DM
    Davis, MD
    Lachin, JM
    Cleary, PA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19): : 2563 - 2569
  • [43] Effects of islet transplantation on microvascular and macrovascular complications in type 1 diabetes
    Reid, Laura
    Baxter, Faye
    Forbes, Shareen
    DIABETIC MEDICINE, 2021, 38 (07)
  • [44] INCREASED INFLAMMATORY ACTIVITY AND CHRONIC MICROVASCULAR COMPLICATIONS IN TYPE 1 DIABETES
    Popovic, D.
    Mitrovic, M.
    Tomic-Naglic, D.
    Vukovic, B.
    Stokic, E.
    Kovacev-Zavisic, B.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A48 - A48
  • [45] Cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus
    Felicio, Joao Soares
    d'Albuquerque Silva, Lilian de Souza
    Pinto Martins, Carlliane Lima e Lins
    Abrahao Neto, Joao Felicio
    de Lemos, Manuela Nascimento
    Resende, Fabricio de Souza
    da Silva, Wanderson Maia
    de Alcantara, Angelica Leite
    Neres Iunes de Oliveira, Maria Clara
    Kzan de Souza Neto, Norberto Jorge
    Farias de Franco, Isabela Imbelloni
    Zahalan, Nathalie Abdallah
    Janau, Luisa Correa
    Contente Braga de Souza, Ana Carolina
    Santos, Flavia Marques
    Marques de Queiroz, Natercia Neves
    Lara Mourao, Neyla Arroyo
    dos Santos, Marcia Costa
    Felicio, Karem Mileo
    Cunha de Melo, Franciane Trindade
    DIABETOLOGY & METABOLIC SYNDROME, 2018, 10
  • [46] Phosphatidylserine expressing microvesicles in relation to microvascular complications in type 1 diabetes
    Bergen, Karin
    Mobarrez, Fariborz
    Joerneskog, Gun
    Wallen, Hakan
    Tehrani, Sara
    THROMBOSIS RESEARCH, 2018, 172 : 158 - 164
  • [47] Inflammation markers are associated with obesity but not with microvascular complications of type 1 diabetes
    Izuora, KE
    Chase, HP
    Jackson, WE
    Coll, JR
    Osberg, IM
    Gottlieb, PA
    Gutin, R
    Rewers, MJ
    Garg, S
    DIABETES, 2004, 53 : A217 - A217
  • [48] Evaluation of microvascular complications in children and adolescents with type 1 diabetes in Indonesia
    Pulungan, A. B.
    Faizi, M.
    Rochmah, N.
    Angela, A.
    Prasasti, E. T.
    Fadiana, G.
    Lubis, S. Mayasari
    Aditiawati, A.
    Ismail, I. Citra
    Cheng, W.
    Yurisa, W.
    Novina, N.
    Faisal, F.
    Nuareni, E.
    Agustiarini, E.
    Utari, A.
    Adelia, S.
    Patria, S. Yudha
    Girimoelyo, A.
    Tjahjono, H. Adji
    Salim, I. Agus
    Mutaqin, F.
    Arimbawa, M.
    Yuda, I. M. Darma
    Himawan, I. W.
    Pateda, V.
    Supit, T. Eduard Absalom
    Artati, R. Dewi
    Suryansyah, A.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 187 - 187
  • [49] Vitamin D Levels, Microvascular Complications, and Mortality in Type 1 Diabetes
    Joergensen, Christel
    Hovind, Peter
    Schmedes, Anne
    Parving, Hans-Henrik
    Rossing, Peter
    DIABETES CARE, 2011, 34 (05) : 1081 - 1085
  • [50] Precision diagnostic approach to predict 5-year risk for microvascular complications in type 1 diabetes
    Al-Sari, Naba
    Kutuzova, Svetlana
    Suvitaival, Tommi
    Henriksen, Peter
    Pociot, Flemming
    Rossing, Peter
    McCloskey, Douglas
    Legido-Quigley, Cristina
    EBIOMEDICINE, 2022, 80